Advanced BioPhotonics enters trial agreement with Beth Israel Deaconess:
This article was originally published in Clinica
Executive Summary
Imaging firm Advanced BioPhotonics has entered into a pilot research agreement with the Beth Israel Deaconess Medical Center (BIDMC) - a teaching hospital of Harvard Medical School. As part of the agreement, BIDMC will be carrying out a clinical trial of the company's patented BioScanIR system, which it says provides a fast, noninvasive, radiation-free method for detecting diseases that affect perfusion and reperfusion in human tissue. The first phase of the trial is scheduled to begin in September 2007, said the Bohemia, New York-based company. The BioScanIR system uses the firm's proprietary DIRI - dynamic infrared imaging - technology, which has been developed for detecting and assessing pigmented lesions of the skin including melanoma and other forms of skin cancer.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.